There was a good deal that was hopeful about this; by then
ANK cells are engineered to incorporate chimeric antigen receptors to target tumor specific antigens (called taNKs) are being developed by NantKwest which lack Killer Inhibitory Receptors (KIR), which cancers can activate to evade NK mediated destruction. Chimeric antigen receptor (CAR) technology is among the most powerful novel cancer therapy approaches currently in development. NantKwest’s lead … Read moreThere was a good deal that was hopeful about this; by then